Outcome of boost haemopoietic stem cell transplant for decresed donor chimerism or graft dysfunction in primary immunodeficiency

Bone Marrow Transplantation

Volumn 35, Issue 7, 2005, Pages 683-689

  Slatter, M A ^a   Bhattacharya, A ^a   Abinun, M ^a   Flood, T J ^a   Cant, A J ^a   Gennery, A R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Allogeneic BMT; Boost infusion; Primary immunodeficiency; Severe combined immunodeficiency; Slipping donor chimerism; T cell depleted BMT

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; IMMUNOGLOBULIN; MELPHALAN; RITUXIMAB; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ARTICLE; B LYMPHOCYTE; CHILD; CHIMERA; CHRONIC GRANULOMATOUS DISEASE; COMBINED IMMUNODEFICIENCY; DISEASE SEVERITY; DONOR; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME; VIRUS INFECTION;

FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOCYTES; RETROSPECTIVE STUDIES; TRANSPLANTATION CHIMERA; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 17144382119     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704872     Document Type: Article

References (23)

1. Antoine C, Muller S, Cant A et al, for the European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003; 361: 553-560.
2. Filipovich AH, Stone JV, Tomany SC et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97 1598-1603.
3. Gennery AR, Khawaja K, Veys P et al. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002. Blood 2004; 103: 1152-1157.
4. Gross TG, Filipovich AH, Conley ME et al. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 1996; 17: 741-744.
5. Seger RA, Gungor T, Belohradsky BH et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 2002; 100: 4344-4350.
6. Baud O, Goulet O, Canioni D et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001; 344: 1758-1762.
7. Buckley RH, Schiff SE, Schiff RI et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508-516.
8. Kline RM, Stiehm ER, Cowan MJ. Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation. Bone Marrow Transplant 1996; 17: 543-548.
9. Amrolia P, Gaspar HB, Hassan A et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000; 96: 1239-1246.
10. Zaucha JM, Gooley T, Bensinger WI et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221-3227.
11. Quinones RR. Hematopoietic engraftment and graft failure after bone marrow transplantation. Am J Pediatr Hematol Oncol 1993; 15: 3-17.
12. Rosenfeld CS, Rybka WB, Weinbaum D et al. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 1995; 23: 626-629.
13. Steffens HP, Podlech J, Kurz S et al. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J Virol 1998; 72: 5006-5015.
14. Johnston RE, Geretti AM, Prentice HG et al. HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. Br J Haematol 1999; 105: 1041-1043.
15. Green A, Clarke E, Hunt L et al. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. Blood 1999; 94: 2236-2246.
16. Remberger M, Ringden O, Ljungman P et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22: 73-78.
17. Rao K, Amrolia PJ, Jones A et al. Improved survival after unrelated donor bone marrow transplant in children with primary immunodeficiency using a reduced intensity conditioning regime. Blood 2004; 105: 879-885.
18. Min CK, Kim DW, Lee JW et al. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation. Acta Haematol 2000; 104: 185-192.
19. Wolff SN. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002; 29: 545-552.
20. Antin JH, Childs R, Filipovich AH et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2001; 7: 473-485.
21. Yamaguchi K, Ariga T, Yamada M et al. Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression. Blood 2002; 100: 1208-1214.
22. Ozsahin H, Le Deist F, Benkerrou M et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J Pediatr 1996; 129: 238-244.
23. Lang P, Klingebiel T, Schumm M et al. Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago. Bone Marrow Transplant 2004; 33: 879-880.